Table: begin end state 1 21 cytoplasmic 22 42 transmembrane 43 52 non-cytoplasmic 53 71 transmembrane 72 77 cytoplasmic 78 99 transmembrane 100 108 non-cytoplasmic 109 128 transmembrane 129 134 cytoplasmic 135 152 transmembrane 153 189 non-cytoplasmic 190 212 transmembrane 213 239 cytoplasmic 240 266 transmembrane 267 318 non-cytoplasmic 319 339 transmembrane 340 360 cytoplasmic 361 379 transmembrane 380 384 non-cytoplasmic 385 407 transmembrane 408 442 cytoplasmic 443 466 transmembrane 467 471 non-cytoplasmic 472 497 transmembrane 498 503 cytoplasmic 504 533 transmembrane 534 538 non-cytoplasmic 539 559 transmembrane 560 567 cytoplasmic 568 588 transmembrane 589 592 non-cytoplasmic 593 617 transmembrane 618 626 cytoplasmic 627 659 transmembrane 660 673 non-cytoplasmic
Input: >WP_086508325.1 NCBI__GCF_002151265.1:WP_086508325.1 MSESANPPVTVPGGNAIQPRPILWLITLVAVGLSLFQLYSAGIQPLGLFYQRSVHLMLIM MLAFLIFPVFGPNRKRGVLGWLIDAAFFAGALITGGYMVLYLDEIIRRAGFWSQTDIIVG CIAVVTVLEASRRAVGLGMTIIGAIAILYAFAGPRGELPWLGQFMPGILEHRGYNLDRVV GQLYLGQEGIFGLPLGVAATFIFVFVLFGAFLESTGAGKFFIDMAYAATGRQRGGPAKAA VIASAGMGSISGSAIANVVTTGAFTIPLMKRLGYKPHQAGGIEAAASTGGQIMPPLMGAG AFLIAEYTNTPYLDVVKVSILPAIMYFATVYLFVHIIALKQGMQGLPKSELPQMRDVLRE GWHFLLPLAVLVWLLAMHMSPMRVGFYAVVTMVAVAALRYTIWFFFVAPRQGQPVTLAST GRVIWAGFVKLIEGLELGARNAVSVSLACAVAGIIVGVVGLTGLGLKFSAMMMAFSGGNI VLALLMVLLASLILGMGLPVTASYIVLIVLVGPALTAEFGIPLLIAHLVVFWYSQDSNVT PPIALAGFAGAAIAGSKPMATGVQAWKFAKGLYLIPMFMVFNPEIIMGGPLHILAWNGLI AILALGAFAAALEGYLFTRMSWLPRIAISGAIVAVFYPNFMVEAVGVAVMILAIGANWLA SRREIHSAGAGTT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server